Classic Hodgkin Lymphoma

• CLINICAL_TRIALS trial_result · 2026-06-30
  Clinical Trial Results: Study of Magrolimab and Pembrolizumab in Relapsed or Refractory Classic Hodgkin Lymphoma [Phase 2]

  Phase 2 trial evaluating magrolimab plus pembrolizumab in relapsed or refractory classic Hodgkin lymphoma has been terminated with results p…

• CLINICAL_TRIALS research · 2026-04-23
  Clinical Trial Update: Pembrolizumab in Combination With Chemotherapy for the Treatment of Frail Hodgkin Lymphoma Patients Ineligible for Standard Treatment [Phase 2]

  A Phase 2 trial is evaluating pembrolizumab in combination with chemotherapy for frail patients with classic Hodgkin lymphoma who are inelig…

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma [Phase 1, Phase 2]

  This clinical trial investigates brentuximab vedotin and nivolumab, with or without ipilimumab, for relapsed or refractory Hodgkin lymphoma …

• CLINICAL_TRIALS trial_result · 2025-09-30
  Clinical Trial Update: Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas [Phase 1, Phase 2]

  This is a completed Phase 1/2 clinical trial from MD Anderson evaluating AFM13 and AFM13-NK in patients with recurrent or refractory CD30-po…

• CLINICAL_TRIALS research · 2025-02-28
  Clinical Trial Update: A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL) [Phase 3]

  A Phase III study is evaluating JS004 plus toripalimab versus investigator-selected chemotherapy in patients with PD-(L)1 monoclonal antibod…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-07-16
  Clinical Trial Update: Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer [Phase 1]

  Phase 1 trial evaluating the addition of pembrolizumab to standard antiretroviral therapy in HIV-positive patients with cancer. The study ha…

• CLINICAL_TRIALS trial_result · 2024-02-01
  Clinical Trial Update: Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL. [Phase 1]

  Phase 1 study of pembrolizumab plus vorinostat in relapsed or refractory B-cell lymphomas and classic Hodgkin lymphoma; results posted in Fe…

• CLINICAL_TRIALS trial_result · 2023-05-31
  Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma [Phase 3]

  Phase 3 trial evaluating brentuximab vedotin in combination chemotherapy for pediatric and young adult Hodgkin lymphoma across advanced-stag…

• CLINICAL_TRIALS trial_result · 2023-04-27
  Clinical Trial Update: Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas [Phase 1, Phase 2]

  Phase 1/2 trial evaluating IMM01 in combination with tislelizumab for advanced solid tumors and Classic Hodgkin lymphoma is ongoing with unk…

• CLINICAL_TRIALS trial_result · 2023-03-16
  Clinical Trial Update: Lowdose Nivolumab in Combination With AVD as Front Line Therapy for Classic Hodgkin's Lymphoma [Phase 2]

  Phase 2 clinical trial evaluating low-dose nivolumab in combination with AVD as frontline therapy for classic Hodgkin's lymphoma; current st…

• CLINICAL_TRIALS trial_result · 2022-09-14
  Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy [Phase 3]

  Phase 3 trial updating efficacy and safety of sintilimab plus ICE versus ICE in patients with classic Hodgkin's lymphoma after failure of fi…

• CLINICAL_TRIALS trial_result · 2020-02-28
  Clinical Trial Update: Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma [Phase 2]

  A Phase 2 trial evaluated combination chemotherapy with or without rituximab in stage III-IV Classic Hodgkin Lymphoma; results have been pos…